A validated stability indicating DAD–HPLC method for determination of pentoxifylline in presence of its pharmacopeial related substances

Moffat, 2004 Sweetman, 2009 U. S. Pharmacopeia 34 National Formulary 29. Asian ed; 2011. B. Pharmacopoeia, The stationary Office, London; 2012. Bauza, 1984, Gas chromatographic determination of pentoxifylline and its major metabolites in human breast milk, J. Chromatogr. B Biomed. Sci. Appl., 310, 61, 10.1016/0378-4347(84)80068-7 Smith, 1983, Determination of pentoxifylline and its major metabolites in microbial extracts by thin-layer and high-performance liquid chromatography, J. Chromatogr. A, 281, 281, 10.1016/S0021-9673(01)87886-9 Grozdanovic, 2005, Development of a HPTLC method for in-process purity testing of pentoxifylline, J. Sep. Sci., 28, 575, 10.1002/jssc.200400006 Shinzawa, 2009, Raman imaging analysis of pharmaceutical tablets by two-dimensional (2D) correlation spectroscopy, Vib. Spectrosc., 51, 125, 10.1016/j.vibspec.2008.11.011 Hegde, 2008, Electrochemical oxidation of pentoxifylline and its analysis in pure and pharmaceutical formulations at a glassy carbon electrode, Anal. Lett., 41, 977, 10.1080/00032710801978228 Korman, 1994, Application of micellar electrokinetic chromatography to the quality control of pharmaceutical formulations: The analysis of xanthine derivatives, Electrophoresis, 15, 1304, 10.1002/elps.11501501198 El Dawy, 2006, Spectrofluorimetric determination of drugs containing active methylene group using N1Methyl nicotinamide chloride as a fluorigenic agent, Chem. Pharm. Bull., 54, 1026, 10.1248/cpb.54.1026 Sastry, 1998, Spectrofluorimetric determination of drugs containing active methylene group using N1-Methyl nicotinamide chloride as a fluorigenic agent, Talanta, 46, 1357, 10.1016/S0039-9140(98)00003-4 Sripalakit, 2009, Validation of an HPLC method for determination of pentoxifylline in human plasma and its application to pharmacokinetic study, J AOAC Inter, 92, 837, 10.1093/jaoac/92.3.837 Pokrajac, 1997, Pharmacokinetics and bioavailability of pentoxifylline in healthy volunteers- a comparative study of three oral formulations, Eur. J. Pharm. Biopharm., 43, 193, 10.1016/S0939-6411(96)00015-X Raoul, 2007, A novel drug interaction between the quinolone antibiotic ciprofloxacin and a chiral metabolite of Pentoxifylline, Biochem. Pharmacol., 74, 639, 10.1016/j.bcp.2007.05.013 Lahsini, 2012, Optimization and validation of a new HPLC method using monolithic column for simultaneous determination of pentoxifylline and related compounds, Pharm. Chem. J., 46, 127, 10.1007/s11094-012-0746-8 Vlase, 2010, Rapid high-performance liquid chromatography-tandam mass spectrometry method for determination of Pentoxifylline and its active metabolites M1 and M5 in human plasma and its application in bioavailability study, Talanta, 82, 945, 10.1016/j.talanta.2010.05.064 Magureanu, 2010, Degradation of pharmaceutical compound pentoxifylline in water by non-thermal treatment, Water Res., 44, 3445, 10.1016/j.watres.2010.03.020 Mone, 2010, Degradation studies of pentoxifylline: Isolation and characterization of a novel gem-dihydroperoxide derivative as major oxidative degradation product, J. Pharm. Biomed. Anal., 53, 335, 10.1016/j.jpba.2010.04.006 Korany MA, Haggag RS, Ragab MAA, Elmallah OA. Kinetic investigation of pentoxifylline based on non-parametric linear regression of derivative and convoluted derivative chromatographic and spectrophotometric responses. J Liq Chromatogr Relat Technol 2012; Accepted for publication. ICH, Q2 (R1). Validation of analytical procedure: Text and methodology, international conference on harmonization: Geneva, (http://www.ich.org/LOB/media/MEDIA417.pdf); 2005. Armitage, 1994 Miller, 2005